Venous thromboembolism and cancer: Prevention of VTE

Thrombosis Research

Volumn 102, Issue 6, 2001, Pages

  Bergqvist, David ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; DANAPAROID; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

CANCER; CANCER PATIENT; CANCER SURGERY; CARDIOVASCULAR RISK; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; EMBOLISM PREVENTION; HIGH RISK POPULATION; HUMAN; LUNG EMBOLISM; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM; THROMBOSIS PREVENTION;

EID: 0035876199     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(01)00241-9     Document Type: Article

References (35)

1. Deep vein thrombosis in patients with superficial thrombophlebitis of the leg
2. Clinical relevance of the fibrinogen uptake test in patients undergoing elective general abdominal surgery - Relation to major thromboembolism and mortality. Fragmin Multicentre Study Group
3. The risk of venous thromboembolism is increased throughout the course of malignant glioma: An evidence-based review
4. Prevention of venous thromboembolism
5. Postoperative pulmonary embolism after hospital discharge. An underestimated risk
6. Thromboembolism in cancer. Changing trends
7. Effects of chemotherapeutic drugs on platelet and metastatic tumor cell-endothelial cell interactions as a model for assessing vascular endothelial integrity
8. Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer
9. Deep venous thrombosis: A continuing problem
10. A 30-year survey of pulmonary embolism verified at autopsy: An analysis of 1274 surgical patients
11. Autopsy-verified pulmonary embolism in a surgical department: Analysis of the period from 1951 to 1988
12. Postoperative fatal pulmonary embolism in a general surgical department
13. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery
14. Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer
15. Late venous thromboembolic disease after radical prostatectomy: Effect of risk factors, warfarin and early discharge
16. Low-molecular-weight heparin (enoxaparin) as prophylitis against venous thromboembolism after total hip replacement
17. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: Double-blind randomised comparison of enoxaparin versus placebo
18. Prolonged thromboprophylaxis following hip replacement surgery - Results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin)
19. Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty - The Danish Prolonged Prophylaxis (DaPP) Study
20. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: A double-blind, randomized comparison
21. Incidence and prevention of deep venous thrombosis occurring late after general surgery: Randomised controlled study of prolonged thromboprophylaxis
22. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double-blind randomized multicentre trial with venographic assessment
23. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery
24. Prophylaxis of postoperative thromboembolism with low molecular weight heparins
25. A randomized trial of low-dose heparin and intermittent pneumatic calf compression for the prevention of deep venous thrombosis after gynecologic oncology surgery
26. Orgaran (Org 10172) or heparin for preventing venous thrombosis after elective surgery for malignant disease? A double-blind, randomised, multicentre comparison
27. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients
28. Upper extremity deep venous thrombosis in cancer patients with venous access devices - Prophylaxis with a low molecular weight heparin (Fragmin)
29. Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin
30. Deep vein thrombosis of the leg. Is there a "high risk" group?
31. A study of pulmonary embolism and deep leg vein thrombosis after major gynaecological surgery using labelled fibrinogen-phlebography and lung scanning
32. Prophylaxis of postoperative leg vein thrombosis by low dose subcutaneous heparin or perioperative calf muscle stimulation: A controlled clinical trial
33. The use of graduated compression stockings in the prevention of postoperative deep vein thrombosis
34. The Multicentre Trial Committee. Dihydriergotamine-heparin prophylaxis of postoperative deep vein thrombosis: A multicentre trial
35. Pre-operative identification of patients at high risk of deep venous thrombosis after elective major abdominal surgery